logo-large
  • Browse Categories

Publications by authors named "Matthew Carraro"

Claim this Profile
L
Long-term efficacy and safety of alemtuzumab in patients with RRMS: 12-year follow-up of CAMMS223.
Brian Steingo, Yaser Al Malik, Ann D Bass, Regina Berkovich, Matthew Carraro

J Neurol· November 2020


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lymphocyte pharmacodynamics are not associated with autoimmunity or efficacy after alemtuzumab.
Heinz Wiendl, Matthew Carraro, Giancarlo Comi, Guillermo Izquierdo, Ho Jin Kim

Neurol Neuroimmunol Neuroinflamm· January 2020


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative effectiveness of dimethyl fumarate versus fingolimod and teriflunomide among MS patients switching from first-generation platform therapies in the US.
Daniel Ontaneda, Jacqueline Nicholas, Matthew Carraro, Jia Zhou, Qiang Hou

Mult Scler Relat Disord· January 2019


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: